Back to search

National and Kapodistrian University of Athens

Μελέτη της ενδοθηλίνης-1 σε παιδιά με κυστική ινώδη νόσο

Abstract

dc:description

Thirty one patients with Cystic Fibrosis (CF) and 28 controls were studied. Sixteen of the patients were girls and 15 boys aged 2-22 years (mean 12.1±5.2 yrs, median 12 yrs). Fourteen of the controls were girls and 14 were boys aged 2-22 yrs (mean 10.6±4.3 yrs, median 10 yrs). The patients (group A) were divided into subgroups A₁ and A₂ according to the severity of their pulmonary disease. Subgroup A₁ included 16 patients aged 5-22 yrs (mean 13.0±4.9 yrs, median 12 yrs) with impaired lung function. Sybgroup A₂ consisted of 15 patients aged 2-22 yrs (mean 11.2±5.5 yrs, median 11 yrs) with good lung function. There was no age or sex difference between the controls (group B) and the patients, as well as between groups A₁, A₂ and B. Patients in subgroups A₁ and A₂ had differences in Shwachman scoring (subgroup A₁: 53.8±9.5, subgroup A₂: 87.4±4.6, p<0.0001), spirometric values (FVC: 41.3±12% in subgroup A₁, 90.0±8.7% in subgroup A₂, p<0.0001) and FEV₁: 41.6±14.4% in subgroup A₁, 96.ó±11.7% in subgroup A₂, p<0.0001) and arterial blood gas values (PO₂: 66.2±13.3 mmHg in subgroup A₁, 95.9±4.8 mmHg in subgroup A₂, p<0.0001 and PCO₂: 42.2±10.1 mmHg in subgroup A₁, 35.6±3.7 mmHg in subgroup A₂, p<0.05). Plasma level of Endothelin-1 (ET-1) were estimated in all the study subjects by radio-immunoassay (RIA). Plasma Atrial Natriuretic Peptide (ANP) and renin activity were measured too, as well as serum aldosterone and serum and urine electrolytes. The results were as following: 1) Plasma ET-1 level in CF patients (1.3-8.4 pg\ml, mean 3.03±1.4 pg\ml) was not significantly different from that of the controls (1.5-3.5 pg\ml, mean 2.48±0.63, p>0.05). However the plasma levels in subgroup A₁ (2.5-8.4 pg\ml, mean 3.78±1.54 pg\ml) were significantly higher than the levels in subgroup A₂ (1.3-3.8 pg\ml mean 2.2±0.7 pg\ml, p<0.001) and group B (p<0.001). Plasma ET-l levels in subgroup A2 and group Β were not significantly different. 2) Plasma ANP level in CF patients (17.8-166.2 pg\ml, mean 37.8±29.2 pg\ml) was not significantly different from that in controls (16.7-42.0 pg\ml, mean 26.9±7.1 pg\ml, p>0.05). However subgroup A₁ had significantly higher plasma levels (22.8-166.2 pg\ml mean 49.2±36.5 pg\ml) than subgroup A₂ (17.8-34.9 pg\ml, mean 24.9±4.9 pg\ml p<0.001) and Group B (p<0.005). 3) Serum aldosterone in CF patients (32.1-1849 pg\ml, mean 353.5±402.2 pg\ml) was significantly different from that in controls (58-430 pg\ml, mean 147.7±107.8 pg\ml, p<0.05). Subgroup A₁ levels (103-1159 pg\ml, mean 434.8±332.1 pg\ml) were also significantly different from controls (p<0.001) as well as from subgroup A₂ levels (32.1-1849 pg\ml, mean 266.8±461.3 pg\ml p<0.01). There was no significant difference in aldosterone levels between subgroup A2 patients and controls (p>0.05). 4) Plasma renin activity in CF patients (16-399 μU\ml, mean 128.7±92.3 μU\ml) was significantly different from that in controls (18-144 μU\ml, mean 66.4±42 μU\ml, p<0.05). Plasma renin activity in subgroup A₁ (16-399 μU\ml, mean 127.9±101.9 μU\ml) was not significantly different from values in subgroup A2 (18-276 μU\ml, mean 129.7±83.8 μU\ml p>0.05) and Group Β (p=0.07), while it was different between subgroup A2 and group Β (p<0.05). 5) Plasma ET-1 level correlated positively with plasma ANP level, serum aldosterone and arterial blood PCO₂ and negatively with arterial blood PO₂, FVC, FEV₁, Shwachman score and Brasfield chest radiograph score. There was no correlation of plasma ET-1 level with patients age. It is concluded that plasma ET-1 level is increased in CF patients with impaired pulmonary function and is related to deterioration of the disease. One might speculate that its raised level is implicated in the pathophysiology of the disease.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
1996

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Siahanidou, S.
  • Σιαχανίδου, Σουλτάνα

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/6100

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Siahanidou, S.; Σιαχανίδου, Σουλτάνα. Μελέτη της ενδοθηλίνης-1 σε παιδιά με κυστική ινώδη νόσο. National and Kapodistrian University of Athens, 1996. http://hdl.handle.net/10442/hedi/6100